Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MIST - Tocagen's Upswing And Other News: The Good Bad And Ugly Of Biopharma


MIST - Tocagen's Upswing And Other News: The Good Bad And Ugly Of Biopharma

Tocagen Continues Merger-Fueled Upswing

Tocagen (TOCA) stock shot up as the company follows through its previous announcement about a merger with Forte Biosciences, an obscure pharmaceuticals firm with FB-401 as its lead candidate. FB-401 is a topical drug designed to treat inflammatory skin conditions. The drug is claimed to have shown promise during its Phase 1/2 study. The results from the study are expected to be published during mid 2020. It is also expected that a Phase 2 trial for evaluating the impact of this drug candidate on treating atopic dermatitis will be

Read more ...

Stock Information

Company Name: Milestone Pharmaceuticals Inc.
Stock Symbol: MIST
Market: NYSE
Website: milestonepharma.com

Menu

MIST MIST Quote MIST Short MIST News MIST Articles MIST Message Board
Get MIST Alerts

News, Short Squeeze, Breakout and More Instantly...